Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,660 | 65,774 | 56,605 | 91,316 | 23,735 |
| Marketable Securities | 11,705 | 66,833 | 154,265 | 82,126 | 89,917 |
| Receivables | 8,042 | 5,770 | 5,511 | 367 | 794 |
| Inventories | 7,294 | 5,267 | 5,121 | 1,704 | N/A |
| TOTAL | $111,736 | $150,320 | $228,373 | $179,175 | $116,987 |
| Non-Current Assets | |||||
| PPE Net | 1,598 | 2,449 | 3,652 | 3,132 | 3,156 |
| Investments And Advances | 0 | 0 | 0 | 2,991 | 22,292 |
| Other Non-Current Assets | 6,695 | 9,389 | 2,789 | 878 | 38 |
| TOTAL | $8,293 | $11,838 | $6,441 | $7,001 | $25,486 |
| Total Assets | $120,029 | $162,158 | $234,814 | $186,176 | $142,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,657 | 2,041 | 1,664 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,144 | 6,932 | 6,570 | 3,878 | 3,589 |
| Accrued Expenses | 27,164 | 16,117 | 15,530 | 12,385 | 5,867 |
| Other current liabilities | 1,902 | 1,858 | 512 | 344 | 287 |
| TOTAL | $34,867 | $26,948 | $24,276 | $16,607 | $9,743 |
| Non-Current Liabilities | |||||
| Long Term Debt | 126,307 | 125,674 | 117,457 | 102,647 | N/A |
| Other Non-Current Liabilities | 8,831 | 10,429 | 3,196 | 796 | 547 |
| TOTAL | $135,138 | $136,103 | $120,653 | $103,443 | $547 |
| Total Liabilities | $170,005 | $163,051 | $144,929 | $120,050 | $10,290 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,568 | 28,013 | 27,449 | 26,807 | 22,220 |
| Common Shares | 34 | 33 | 32 | 28 | 27 |
| Retained earnings | -505,287 | -447,884 | -342,698 | -211,699 | -122,209 |
| Other shareholders' equity | 0 | 16 | -264 | -167 | -193 |
| TOTAL | $-49,976 | $-893 | $89,885 | $66,126 | $132,183 |
| Total Liabilities And Equity | $120,029 | $162,158 | $234,814 | $186,176 | $142,473 |